4 Patients being considered for kidney transplant

4 Patients being considered for kidney transplant

4.1 Transplant specialists should discuss the risks and benefits of transplantation in the context of COVID‑19 with patients and their families and carers (as appropriate). For further information, see British Transplantation Society and NHS Blood and Transplant guidance for clinicians on consent for solid organ transplantation in adults, children and young people and living organ donation in the context of COVID-19.

4.2 For patients on the kidney transplant waiting list who have received a letter telling them they are at high risk of severe illness from COVID‑19:

4.3 If patients on the kidney transplant waiting list need dialysis, see the NICE rapid guideline on dialysis service delivery for guidance on minimising their risk of contracting COVID‑19.

4.4 For patients on the kidney transplant waiting list who have symptoms of COVID‑19:

  • suspend them from the waiting list, and do nasopharyngeal swab testing for SARS‑CoV‑2

  • if the test is negative, assess the likelihood that they may have COVID‑19 before returning them to the waiting list (because a negative result does not definitely rule out infection)

  • if the test is positive, assess whether they are well enough to return to the waiting list when they have:

    • recovered from COVID‑19

    • been symptom-free for at least 28 days

    • had a negative swab test result for SARS‑CoV‑2.

4.5 For patients who have been scheduled for a living donor transplant, tell them and members of their household to self-isolate for 14 days before the transplant.

4.6 For patients who have been scheduled for a living donor transplant and who need dialysis in the 14 days before their transplant, do this in a COVID‑19‑secure area.